Targeting LSD1 in cancer: molecular elucidation and recent advances

W Cai, C Xiao, T Fan, Z Deng, D Wang, Y Liu, C Li… - Cancer Letters, 2024 - Elsevier
Histones are the main components of chromatin, functioning as an instructive scaffold to
maintain chromosome structure and regulate gene expression. The dysregulation of histone …

[HTML][HTML] A multidimensional analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in the bone marrow of pediatric acute myeloid …

JB Koedijk, I van der Werf, L Penter, MA Vermeulen… - medRxiv, 2023 - ncbi.nlm.nih.gov
Because of the low mutational burden, children with acute myeloid leukemia (AML) are
thought to have a 'cold'tumor microenvironment and consequently, a low likelihood of …

A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives

M Montoya, M Gallus, S Phyu, J Haegelin, J de Groot… - Cells, 2024 - mdpi.com
Glioblastoma (GBM) is the most common primary malignant brain tumor, with a median
overall survival of less than 2 years and a nearly 100% mortality rate under standard therapy …

Impact of in vivo fate of STING agonist-loaded lipid nanoparticles on antitumor immunity

R Endo, T Ueda, T Nagaoki, N Shima, Y Sato… - Journal of Controlled …, 2024 - Elsevier
Therapeutically manipulating the stimulator of interferon genes (STING) pathway has
promising potential for enhancing antitumor immunity. Agonists of this pathway (STING …

SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity

S Ilangumaran, Y Gui, A Shukla… - Frontiers in …, 2024 - frontiersin.org
Suppressor of cytokine signaling 1 (SOCS1) is a potent regulator immune cell responses
and a proven tumor suppressor. Inhibition of SOCS1 in T cells can boost antitumor immunity …

Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma

M Pourmaleki, CJ Jones, SD Mellinghoff… - Clinical Cancer …, 2024 - aacrjournals.org
Abstract Purpose: Classic Hodgkin lymphoma (cHL) is a B-cell lymphoma that occurs
primarily in young adults and, less frequently, in elderly individuals. A hallmark of cHL is the …

[HTML][HTML] Mononuclear Phagocytes, Cellular Immunity, and Nobel Prizes: A Historic Perspective

S Gordon, A Roberti, SHE Kaufmann - Cells, 2024 - mdpi.com
The mononuclear phagocyte system includes monocytes, macrophages, some dendritic
cells, and multinuclear giant cells. These cell populations display marked heterogeneity …

[HTML][HTML] Unveiling spatial complexity in solid tumor immune microenvironments through multiplexed imaging

S Scheuermann, B Kristmann, F Engelmann… - Frontiers in …, 2024 - frontiersin.org
Deciphering cellular components and the spatial interaction network of the tumor immune
microenvironment (TIME) of solid tumors is pivotal for understanding biologically relevant …

Unraveling a hidden player in lymphovascular invasion in bladder cancer

B Wolf, RK Jain - Cancer Cell, 2024 - Elsevier
Tumor invasion into the lymphatic vasculature represents a critical step during malignant
progression of epithelial cancers. In this issue of Cancer Cell, Zheng et al. unravel how …

Tumor eradication by triplet therapy with BRAF inhibitor, TLR 7 agonist, and PD‐1 antibody for BRAF‐mutated melanoma

K Nakamura, T Yaguchi, M Murata, Y Ota… - Cancer …, 2024 - Wiley Online Library
Abstract Programmed death 1 (PD‐1)/programmed death‐ligand 1 inhibitors are commonly
used to treat various cancers, including melanoma. However, their efficacy as monotherapy …